Jay R. Luly
2020
Compensation breakdown
| Non-Equity Incentive Plan | $415,716 |
|---|---|
| Option Awards | $3,598,848 |
| Salary | $667,063 |
| Stock Awards | $497,039 |
| Other | $19,171 |
| Total | $5,197,837 |
Luly received $3.6M in option awards, accounting for 69% of the total pay in 2020.
Luly also received $415.7K in non-equity incentive plan, $667.1K in salary, $497K in stock awards and $19.2K in other compensation.
Rankings
In 2020, Jay R. Luly's compensation ranked 2,110th out of 13,090 executives tracked by ExecPay. In other words, Luly earned more than 83.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,110 out of 13,090 | 84th |
Division Manufacturing | 808 out of 5,624 | 86th |
Major group Chemicals And Allied Products | 288 out of 2,257 | 87th |
Industry group Drugs | 244 out of 1,957 | 88th |
Industry Pharmaceutical Preparations | 173 out of 1,462 | 88th |
Pay ratio
| Jay R. Luly's Pay | $5,197,837 |
|---|---|
| Median Employee's Pay | $232,629 |
| Pay Ratio | 22to 1 |
In 2020, the annual total compensation of Jay R. Luly was $5,197,837.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $232,629.
The ratio of Jay R. Luly's pay to the pay of median employee was therefore 22 to one.
Luly's colleagues
We found four more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2020.
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019